Multiorganism, drug-resistant keratitis treated by corneal crosslinking.

Details

Serval ID
serval:BIB_0642DBBCDA14
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Multiorganism, drug-resistant keratitis treated by corneal crosslinking.
Journal
European journal of ophthalmology
Author(s)
Kymionis G.D., Kouroupaki A.I., Liakopoulos D.A., Arandjelovic I.R., Tsoulnaras K.I.
ISSN
1724-6016 (Electronic)
ISSN-L
1120-6721
Publication state
Published
Issued date
01/07/2016
Peer-reviewed
Oui
Volume
26
Number
4
Pages
e67-e70
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
To describe a case of multiorganism, drug-resistant keratitis that responded well to corneal crosslinking (CXL) treatment.
A 52-year-old man presented to our institute with a 2-month ocular history of infectious keratitis in his right eye, on topical antibacterial, antifungal, and antiprotozoan treatment, and complained of increase in pain, discomfort, and visual deterioration. Slit-lamp examination revealed advanced infectious keratitis (extensive deep corneal infiltrate with perineuritis). Cultural and molecular analysis of obtained corneal specimens demonstrated combined fungal and Acanthamoeba infection; confocal microscopy confirmed Acanthamoeba infection. Intense targeted topical antifungal and antiprotozoan treatment was initiated immediately and 1 month later CXL was performed due to drug resistance of the infection.
Two weeks after CXL treatment, the corneal findings had deteriorated, while a corneal abscess was formed and extended at almost half of the cornea. This was gradually limited and the corneal infiltrate and abscess were eventually decreased. In addition, the symptoms improved.
Corneal crosslinking could be an effective therapy in the management of advanced infectious keratitis unresponsive to conventional medical treatment.
Pubmed
Web of science
Create date
01/10/2019 13:33
Last modification date
06/10/2019 6:26
Usage data